Profil
Hanns-Peter Wiese worked as a Director at Coapt Systems, Inc. and as a Managing Director & Partner at The Global Life Science Ventures GmbH.
He holds an MBA from the University of Hamburg.
Anciens postes connus de Hanns-Peter Wiese
| Sociétés | Poste | Fin |
|---|---|---|
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Private Equity Investor | 31/12/2014 |
Coapt Systems, Inc.
Coapt Systems, Inc. BiotechnologyHealth Technology Manufactures and markets bioabsorbable implants | Directeur/Membre du Conseil | - |
Formation de Hanns-Peter Wiese
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Coapt Systems, Inc.
Coapt Systems, Inc. BiotechnologyHealth Technology Manufactures and markets bioabsorbable implants | Health Technology |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Finance |
University of Hamburg
University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















